Institute of Oncology Hematology Biomedical Research

Laredo, Texas 78041

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Chronic Phase Chronic Myeloid Leukemia, Multiple Myeloma

Studies at this site

• Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib — Completed
• Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment — Completed